The latest tumor marker in gastric cancer
Ogoshi, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 4): 513-520
2001
ISSN/ISBN: 0047-1852 PMID: 11424436 Document Number: 540050
Document emailed within 1 workday
Related Documents
Ubukata, H.; Katano, M.; Motohashi, G.; Kasuga, T.; Takemura, A.; Tabuchi, T.; Tabuchi, T. 2003: Evaluation of CA72-4 as a tumor marker in patients with gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(11): 1821-1824Xie, J.-w.; Huang, C.-m.; Zheng, C.-h.; Li, P.; Wang, J.-b.; Lin, J.-x.; Lu, J. 2013: Expression tumor stem cell surface marker CD44 in gastric cancer and its significance Zhonghua Wei Chang Wai Ke Za Zhi 16(11): 1107-1112
Hardt, P.D.; Ngoumou, B.K.; Rupp, J.; Schnell-Kretschmer, H.; Kloer, H.U. 2000: Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer Anticancer Research 20(6d): 4965-4968
Kos, T.; Aksoy, S.; Sendur, M.A.N.; Arik, Z.; Civelek, B.; Kandemir, N.; Ozdemir, N.Y.; Zengin, N.; Altundag, K. 2013: Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes Journal of BUON: Official Journal of the Balkan Union of Oncology 18(3): 608-613
Kimura, E.; Murae, M.; Koga, R.; Odawara, Y.; Nakabayashi, Y.; Yokoyama, K.; Nakata, H.; Totake, T.; Ochiai, K.; Yasuda, M. 1984: Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer Nihon Sanka Fujinka Gakkai Zasshi 36(11): 2121-2128
Karayiannakis, A.J.; Syrigos, K.N.; Chatzigianni, E.; Papanikolaou, S.; Karatzas, G. 1998: E-cadherin expression as a differentiation marker in gastric cancer Hepato-Gastroenterology 45(24): 2437-2442
Matsumoto, S.; Takayama, T.; Wakatsuki, K.; Tanaka, T.; Migita, K.; Ito, M.; Nakajima, Y. 2015: Palliative Surgery for Gastric Cancer with Gastric Outlet Obstruction or Anemia due to Tumor Bleeding Hepato-Gastroenterology 62(140): 1041-1046
Cappellari, A.; Bagarella, M.; Corradi, G. 1990: Clinical value of a new tumor marker (M.C.A.) in the breast cancer follow-up Bollettino dell'Istituto Sieroterapico Milanese 69(1): 315-318
Oremek, G.; Kukshaĭte, R.; Sapoutzis, N.; Ziolkowski, P. 2007: The significance of TU M2-PK tumor marker for lung cancer diagnostics Klinicheskaia Meditsina 85(7): 56-58
Kikuchi, K.; Uematsu, Y.; Takada, Y.; Kurihara, E.; Suito, T.; Fujisaki, M.; Takahashi, R.; Tamura, T. 1987: Evaluation of tumor marker CA15-3 in breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(11): 3095-3100
Zheng, G.; Cheng, X.; Wang, L.; Xu, Z.; Gao, X.; Yu, P.; Lyu, H.; Huang, T.; Chen, J. 2017: Correlation of MRi apparent diffusion coeffcient with molecular marker Ki-67 in gastric cancer Zhonghua Wei Chang Wai Ke Za Zhi 20(7): 803-808
Hu, H.; Li, C.; Cai, S.; Zhu, C.; Tian, Y.; Zheng, J.; Hu, J.; Chen, C.; Liu, W. 2014: Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer Hepato-Gastroenterology 61(133): 1478-1482
Roisman, I.; Shiloni, E.; Lifshiz, I.; Shoshani, D.; Saphir, D.; Honigman, I.; Livni, N.; Sherman, Y.; Papo, O.; Durst, A.L. 1992: CA15-3 tumor marker in early detection of breast cancer Harefuah 122(4): 213-218
Venot, J.; Vincent, D.; Clement, M.N.; Beck, C. 1984: Evaluation of a tumor marker of pancreatic cancer. Preliminary results Presse Medicale 13(7): 440-441
Oremek, G.M.; Eigenbrodt, E.; Rädle, J.; Zeuzem, S.; Seiffert, U.B. 1997: Value of the serum levels of the tumor marker TUM2-PK in pancreatic cancer Anticancer Research 17(4b): 3031-3033
Smith, J.A.; Scaletsky, R. 1993: Future directions in tumor marker technology for prostate cancer Urologic Clinics of North America 20(4): 771-777
Miyahara, E.; Toi, M.; Wada, T.; Yamada, H.; Osaki, A.; Yanagawa, E.; Toge, T. 1990: The expression of NCC-ST-439, a tumor marker, in human breast cancer patients Gan no Rinsho. Japan Journal of Cancer Clinics 36(11): 2023-2026
Okholm, C.; Thorsteinsson, M.; Achiam, M.P. 2014: Circulating tumour cells is a promising prognostic and predictive marker of gastric cancer Ugeskrift for Laeger 176(32): 1490-1493
Neri, B.; Comparini, T.; Ciatto, S.; Cataliotti, L.; Distante, V.; Bartalucci, S. 1985: Circulating immune complexes (CIC) as tumor marker in the follow-up of breast cancer Cancer Detection and Prevention 8(1-2): 53-56
Ishimori, A.; Kawamura, T.; Koizumi, F. 1989: Practice of clinical preventive medicine in screening of cancer by tumor marker Rinsho Byori. Japanese Journal of Clinical Pathology 37(6): 599-611